NIH plans to cut back animal testing in federally funded analysis


Thank you for reading this post, don't forget to subscribe!

Ed Silverman, a senior author and Pharmalot columnist at STAT, has been protecting the pharmaceutical business for practically three a long time.

In a major transfer, the U.S. Nationwide Institutes for Well being mentioned it could scale back its reliance on animals in federally funded analysis and as a substitute prioritize funding in human-based alternate options, the second time this month {that a} key authorities company has taken such a step.

To realize its aim, the NIH plans to determine a brand new workplace for overseeing revolutionary analysis and coordinating agency-wide efforts to “develop, validate and scale” using “non-animal approaches” to biomedical analysis. The brand new workplace can even broaden funding and coaching with an eye fixed towards assessing appropriate analysis strategies and make them extra accessible to researchers.

“For many years, our biomedical analysis system has relied closely on animal fashions. With this initiative, NIH is ushering in a brand new period of innovation,” Director Jay Bhattacharya mentioned in a assertion.

STAT+ Unique Story

STAT+





This text is unique to STAT+ subscribers

Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.

Have already got an account? Log in

View All Plans

To learn the remainder of this story subscribe to STAT+.

Subscribe